Dr. Patrick Borgen on Breast Cancer Becoming More a Medical Disease Than Surgical
Patrick Borgen, MD, says this is due to earlier diagnoses, better class prediction through genomic profiling and characteristics of the disease, as well as targeted therapies.
Patrick Borgen, MD, chair, Department of Surgery, director, Maimonides Breast Cancer Center, talks about how breast cancer is becoming less of a surgical disease and more of a medical disease. Borgen says this is due to earlier diagnoses, better class prediction through genomic profiling and characteristics of the disease, as well as targeted therapies.
Borgen says the sequence for treating breast cancer has shifted as well. The sequence has historically been surgery, therapy and then radiation, though more and more patients are starting with treatment. Borgen says these treatments are capable of sterilizing the disease and, alongside medical professionals’ greater understanding of the disease, treatment has become better over the years.
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
Acalabrutinib/Obinutuzumab Shows Improved PFS in Treatment-Naive CLL
April 10th 2024In an interview with Targeted Oncology, Jeff Sharman, MD, discussed the results of the ELEVATE-TN trial of acalabrutinib with or without obinutuzumab at 74.5 months of follow-up among patients with chronic lymphocytic leukemia.
Read More
